5-Amino-1MQ for Fat Loss

What is 5-Amino-1MQ?

5-Amino-1MQ is a small molecule that blocks the enzyme NNMT, which sits inside fat cells and helps set their metabolic rate (Neelakantan et al., 2018). NNMT stands for nicotinamide N-methyltransferase. When NNMT is overactive in white fat tissue, cells tend to store more energy. By inhibiting that enzyme, researchers set out to test whether fat cells would shift toward burning energy instead of storing it. This is a research compound. It is not an approved drug, and the evidence base below is preclinical.

What does research report on 5-Amino-1MQ and fat mass?

In a mouse study, 5-Amino-1MQ reduced body weight and white adipose tissue without lowering food intake (Neelakantan et al., 2018). The study used diet-induced obese mice, a standard model for testing metabolic compounds. Researchers reported that daily treatment at about 20 mg/kg lowered body weight and shrank white fat depots. Importantly, the mice did not eat less. That detail matters because it points to a metabolic mechanism inside the fat cell rather than an appetite effect. This contrasts with the GLP-1 class, where trials in humans tie weight loss partly to reduced intake (Wilding et al., 2021).

To be clear: this is mouse data. The finding has not been reproduced in a completed human trial, so it should be read as a hypothesis for human metabolism, not a demonstrated effect.

How does 5-Amino-1MQ compare to appetite-driven agents?

The reported difference is mechanism: 5-Amino-1MQ acted on fat cell metabolism in mice, while GLP-1 agents reduce intake in people. The table below sets the frame. It is a comparison of what published research reports, not a ranking or a recommendation.

The key gap: two of these have large human trials. 5-Amino-1MQ does not.

What dose did the research use?

Published research reported about 20 mg/kg/day in mice, given daily, in the diet-induced obesity model (Neelakantan et al., 2018). This is a research-reported figure in an animal study. It is not a human dose, and it does not convert simply to a human dose. Animal-to-human scaling is not linear, and no clinical trial has established a human range. The table below states the reported context only.

If you are asking what a person should take, that question routes to a qualified clinician. This page describes the literature only and does not prescribe, recommend, or guide any personal use.

Are there human trials on 5-Amino-1MQ for fat loss?

No completed human trials on 5-Amino-1MQ for fat loss are available in the cited literature. The fat-mass evidence is limited to the mouse study above (Neelakantan et al., 2018). That means safety, effective range, long-term effects, and real-world outcomes in people are not established. Any claim that 5-Amino-1MQ reduces body fat in humans goes beyond the current evidence.

Why is NNMT a research target at all?

NNMT activity in fat tissue is linked to how fat cells handle energy, which made it a candidate for metabolic research (Neelakantan et al., 2018). The idea researchers tested is that turning down this enzyme could push fat cells toward using energy rather than storing it. In the mouse model, blocking NNMT with 5-Amino-1MQ tracked with lower body weight and less white fat (Neelakantan et al., 2018). The mechanism is biologically interesting, but interesting in mice is not the same as proven in people.